Global Antisense And Rnai Therapeutics Market Size & Outlook
Global antisense and rnai therapeutics market, 2018-2030 (US$M)
Related Markets
Global antisense and rnai therapeutics market highlights
- The global antisense and rnai therapeutics market generated a revenue of USD 4,384.9 million in 2023 and is expected to reach USD 14,348.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 18.5% by 2030.
- In terms of segment, antisense rna accounted for a revenue of USD 3,020.9 million in 2023.
- RNA Interference is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Australia is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 4,384.9 million |
| Market revenue in 2030 | USD 14,348.5 million |
| Growth rate | 18.5% (CAGR from 2023 to 2030) |
| Largest segment | Antisense rna |
| Fastest growing segment | RNA Interference |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | RNA Interference, Antisense RNA |
Other key industry trends
- In terms of revenue, the North America accounted for 64.4% of the global antisense and rnai therapeutics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Australia is the fastest growing regional market and is projected to reach USD 153.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antisense And RNAi Therapeutics Market Scope
Antisense And RNAi Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global antisense and rnai therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antisense and rnai therapeutics market will help companies and investors design strategic landscapes.
Antisense rna was the largest segment with a revenue share of 68.89% in 2024. Horizon Databook has segmented the Global antisense and rnai therapeutics market based on rna interference, antisense rna covering the revenue growth of each sub-segment from 2018 to 2030.
The global antisense and RNAi therapeutics market is expected to exhibit lucrative growth in the forecast period with many companies engaged in the investigation of new therapeutics. Companies in an attempt to maintain their market share are engaged in extensive R&D for the development of novel drugs for treatment of different disorders.
The RNAi therapeutic segment holds an extensive product portfolio in the pipeline and future commercialization of these products is expected to drive the market over the next 6 years. Major products present in different phases of discovery, development, or clinical phases of trials cover the treatment of cancer and cholesterol-associated disorders.
Reasons to subscribe to Global antisense and rnai therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global antisense and rnai therapeutics market databook
-
Our clientele includes a mix of antisense and rnai therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global antisense and rnai therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global antisense and rnai therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global antisense and rnai therapeutics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Antisense and rnai therapeutics market size, 2024 (US$M)
Global antisense and rnai therapeutics market share, by technology, 2024 & 2030 (%, US$M)
Antisense and rnai therapeutics market: Opportunity assessment by country
Global antisense and rnai therapeutics market, by region, 2024 (US$M)
| Technology | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1,207.7 | 1,484.4 | 1,548.7 | 1,659.8 | 2,133.2 | 2,822.4 | 3,307.0 | 3,892.8 | 4,603.8 | 5,471.1 | 6,534.2 | 7,843.8 | 9,465.2 | 19.5% |
| Europe | 527.6 | 749.5 | 885.2 | 1,028.6 | 1,018.5 | 884.6 | 1,031.6 | 1,207.9 | 1,420.3 | 1,677.3 | 1,989.5 | 2,370.3 | 2,836.9 | 18.6% |
| Asia Pacific | 281.4 | 409.9 | 465.2 | 521.7 | 477.8 | 502.0 | 582.7 | 678.9 | 794.1 | 932.4 | 1,099.0 | 1,300.6 | 1,545.3 | 17.9% |
| Latin America | 23.1 | 33.5 | 47.5 | 50.3 | 55.8 | 80.1 | 92.3 | 106.6 | 123.6 | 143.7 | 167.6 | 196.1 | 230.2 | 16.6% |
| MEA | 0.0 | 9.3 | 15.3 | 57.3 | 97.6 | 95.9 | 110.2 | 127.0 | 146.9 | 170.4 | 198.2 | 231.4 | 270.9 | 16.4% |
| Overall | 2,039.8 | 2,686.5 | 2,961.9 | 3,317.7 | 3,782.8 | 4,384.9 | 5,123.8 | 6,013.2 | 7,088.7 | 8,394.9 | 9,988.6 | 11,942.2 | 14,348.5 | 19.0% |
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
